References
- HedegaardHChenLHWarnerMDrug-poisoning deaths involving heroin: United States, 2000–2013NCHS Data Brief201519018
- RuddRASethPDavidFSchollLIncreases in drug and opioid-involved overdose deaths – United States, 2010–2015MMWR Morb Mortal Wkly Rep20166550511445145228033313
- Centers for Disease Control and Prevention (CDC)Understanding the Epidemic2017 Available from: https://www.cdc.gov/drugoverdose/epidemic/index.htmlAccessed June 20, 2017
- National Institute of Health (NIH)National Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain2017 Available from: https://iprcc.nih.gov/docs/HHSNational_Pain_Strategy.pdfAccessed June 15, 2017
- Van ZeeAThe promotion and marketing of oxycontin: commercial triumph, public health tragedyAm J Public Health200999222122718799767
- VolkowNDFriedenTRHydePSChaSSMedication-assisted therapies—tackling the opioid-overdose epidemicN Engl J Med2014370222063206624758595
- JonesCMPaulozziLJMackKASources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008–2011JAMA Intern Med2014174580280324589763
- Centers for Disease Control and Prevention (CDC)CDC grand rounds: prescription drug overdoses – a U.S. epidemicMMWR Morb Mortal Wkly Rep201261101322237030
- BrummelALustigAWestrichKBest practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy managementJ Manag Care Pharm2014201211521158
- GreenTCDauriaEFBratbergJDavisCSWalleyAYOrienting patients to greater opioid safety: models of community pharmacy-based naloxoneHarm Reduct J2015122526245865
- Centers for Disease Control and Prevention (CDC)Collaborative Practice Agreements and Pharmacists’ Patient Care Services. A Resource for Decision MakersAtlanta, GACenters for Disease Control and Prevention (CDC)2013
- National Association of Chain Drug Stores (NACDS)Pharmacy: The Face of Neighborhood Health Care in America. RX IMPACT. 2017Arlington, VANACDS2017
- American Society of Health-System Pharmacists (ASHP)ASHP statement on the pharmacist’s role in substance abuse prevention, education, and assistanceAm J Health Syst Pharm201471324324624429020
- BachyryczAShresthaSBleskeBETinkerDBakhirevaLNOpioid overdose prevention through pharmacy-based naloxone prescription program: innovations in health care deliverySubst Abus2017381556027164192
- CochranGFieldCLawsonKPharmacists’ knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacistsJ Pharm Health Serv Res2013427179
- HagemeierNEMurawskiMMLopezNCAlamianAPackRPTheoretical exploration of Tennessee community pharmacists’ perceptions regarding opioid pain reliever abuse communicationRes Social Adm Pharm201410356257523981913
- HagemeierNEAlamianAMurawskiMMPackRPFactors associated with provision of addiction treatment information by community pharmacistsJ Subst Abuse Treat201552677225491734
- Bureau of Justice AssistancePrescription Drug Monitoring Program (PDMP) Program Performance Report2016 Available from: https://www.bja.gov/Publications/PDMP_PPR_Jan-Dec13.pdfAccessed June 13, 2017
- GreenTCMannMRBowmanSEHow does use of a prescription monitoring program change pharmacy practice?J Am Pharm Assoc (2003)201353327328123699676
- NorwoodCWWrightERIntegration of prescription drug monitoring programs (PDMP) in pharmacy practice: improving clinical decision-making and supporting a pharmacist’s professional judgmentRes Social Adm Pharm201612225726626143489